Shares of Sernova Corp. (TSE:SVA – Get Free Report) hit a new 52-week low on Monday . The stock traded as low as C$0.20 and last traded at C$0.20, with a volume of 201261 shares changing hands. The stock had previously closed at C$0.21.
Sernova Price Performance
The stock has a market cap of C$65.06 million, a PE ratio of -1.54 and a beta of 1.35. The stock’s fifty day moving average is C$0.23 and its 200-day moving average is C$0.25. The company has a debt-to-equity ratio of 16.55, a current ratio of 0.32 and a quick ratio of 18.11.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- Financial Services Stocks Investing
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- The 3 Best Retail Stocks to Shop for in August
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
